Kívés Zsuzsanna, Bódis József, Hunyady Béla, Pónusz-Kovács Dalma, Elmer Diána, Kajos Fanni Luca, Csákvári Tímea, Vajda Réka, Boncz Imre
Egészségtudományi Kar, Pécsi Tudományegyetem, Egészségbiztosítási Intézet, Pécs, Hungary.
Általános Orvostudományi Kar, Klinikai Központ, Pécsi Tudományegyetem, I. Sz. Belgyógyászati Klinika, Gasztroenterológiai Tanszék, Pécs, Hungary.
Magy Onkol. 2022 Oct 5;66(3):209-217. Epub 2022 Sep 23.
The aim of our study is to analyse the participation indicators of colorectal cancer screening between 2008-2021. Data derived from the nationwide financing database of the Hungarian National Health Insurance Fund Management. We analysed both diagnostic and screening examinations. According to our results, the screening rate was low, varying between 5.1-6.8% in the years examined. Between 2008 and 2019, the number of participating patients increased slightly. The highest number of patients can be observed in 2019 (178,568 people). In 2020 and 2021, we see a significant decrease, which is a consequence of the COVID-19 pandemic. In the number of patients of the entire examined period (2,233,963 people, 938,223 men, 1,295,740 women), the largest proportion was fecal blood detection by immunochemical method (OENO code: 22631). In 2021, at the county level, the highest number of patients can be seen in Csongrád-Csanád county (994 patients/10,000 people), and the least in Békés county (218 patients/10,000 people). The participation rate of women is higher than that of men in all counties. Participation in colorectal screening is very low. In order to prevent colorectal cancer death, it is necessary to increase the participation rate.
我们研究的目的是分析2008年至2021年期间结直肠癌筛查的参与指标。数据来源于匈牙利国家健康保险基金管理的全国性融资数据库。我们分析了诊断性检查和筛查性检查。根据我们的结果，筛查率较低，在所研究的年份中，筛查率在5.1%至6.8%之间波动。2008年至2019年期间，参与筛查的患者数量略有增加。2019年观察到的患者数量最多（178,568人）。在2020年和2021年，我们看到参与人数显著下降，这是新冠疫情的结果。在整个研究期间的患者总数（2,233,963人，男性938,223人，女性1,295,740人）中，最大比例的检查是免疫化学法粪便潜血检测（OENO代码：22631）。2021年，在县级层面，参与人数最多的是琼格拉德-乔纳德县（994例患者/万人），最少的是贝凯什县（218例患者/万人）。所有县中女性的参与率均高于男性。结直肠癌筛查的参与率非常低。为了预防结直肠癌死亡，有必要提高参与率。
